Vinay Prasad might well have made his contrarian points without invoking the specter of the Third Reich. He didn’t have to go there—but he did. Voluntarily.
There is reason for concern about fascism rising in the United States. The reason is primarily Trumpism, followed by racism, followed by right-wing seditionist impulses.
Francis Collins will step down as director of NIH by the end of 2021, closing out a chapter in his career as the longest-serving presidentially appointed NIH director.
Thomas A. Waldmann, chief emeritus of the NCI Lymphoid Malignancies Branch and NIH Distinguished Investigator, died Sept. 25. He was 91.
Emil J Freireich, a trailblazing oncologist who developed groundbreaking therapies for childhood leukemia, and one of the 60 original members of ASCO, died Feb. 1.
Stand Up To Cancer (SU2C), Exact Sciences, and Providence announced funding for a new Dream Team dedicated to addressing colorectal cancer disparities. The SU2C Colorectal Cancer Health Equity Dream Team will receive a total of $8 million—$6 million from Exact Sciences and $2 million from Providence.
Michael Diaz was named president and managing physician at Florida Cancer Specialists and Research Institute.
Two Mount Sinai cancer researchers will be awarded $4 million in total costs from the National Institutes of Health Common Fund, which supports high-impact programs and research by junior scientists around the country.
Rich Preyer and Marilyn Jacobs Preyer of Hillsborough, North Carolina donated $1 million to support the latest phase of UNC Lineberger Comprehensive Cancer Center’s Carolina Breast Cancer Study, which is investigating how the causes, treatments, and long-term outcomes of breast cancer differ between Black and white women.
One in seven cancer patients around the world missed out on potentially life-saving operations during COVID-19 lockdowns, a study from the University of Birmingham in the U.K. found.
